FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 90 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR ‘Jeopardy!’ Legend James Holzhauer Donates Portion Of Winnings To Cancer Walk... June 24, 2019 Mathew Knowles, Father Of Beyoncé, Fought And Beat Breast Cancer November 5, 2019 This Bar of Soap with a Lump Will Help You Remember... May 31, 2019 New Class of Compounds Rewires Cancer Cells to Self-Destruct August 29, 2023 Load more HOT NEWS Olaparib Maintenance Fails in Platinum Sensitive Advanced Non-Small Cell Lung Cancer Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Endometrial Cancer Fatiga relacionada con el cáncer: Lo que las personas con cáncer...
